@MXene纳米片与协同作用的I型和II型PDT用于抗骨髓瘤
Bingxin Zheng1, Ranran Zhang2, Fei Kuang3
1Department of Orthopedic Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Peoples Republic of China. bonetumoryb@qdu.edu.cn.
Journal of materials chemistry. B
|January 31, 2024
概括
这项研究引入了CeO2@MXene混合物,用于在缺氧瘤中增强光动力疗法 (PDT). 这些杂交物产生氧气和活性氧物种,提高癌症治疗效率.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 光动力疗法 (PDT) 是一种有前途的非侵入性癌症治疗方法.
- 传统的II型PDT在低氧瘤中受限,因为依赖氧气.
- 缺氧瘤需要替代治疗策略来进行有效的治疗.
研究的目的:
- 设计和合成CeO2/Ti3C2-MXene (CeO2@MXene) 混合物,以改善PDT.
- 研究I型和II型PDT机制的协同效应.
- 在低氧瘤环境中增强治疗效果.
主要方法:
- 在Ti3C2-MXene纳米板上CeO2纳米颗粒的现场生长.
- 利用CeO2@MXene.的降解氧化 (REDOX) 特性.
- 通过I型和II型机制评估反应性氧物种 (ROS) 的产生.
主要成果:
- 成功合成了CeO2@MXene混合物.
- 在CeO2@MXene中的REDOX中心与H2O2反应产生氧气,克服缺氧.
- 实现了I型和II型PDT机制的协同作用,产生了各种ROS.
- 异构结的纳米酶功能改善了癌症治疗结果.
结论:
- CeO2@MXene混合物为协同作用的I型和II型PDT提供了一种新的方法.
- 这一策略有效地解决了瘤治疗中缺氧的挑战.
- 开发的材料显示了增强癌症治疗的潜力.
更多相关视频
09:45Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
8.5K
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.0K
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
